Pursue Wealth Partners LLC Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Pursue Wealth Partners LLC raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.3% during the 2nd quarter, Holdings Channel.com reports. The fund owned 13,577 shares of the exchange traded fund’s stock after acquiring an additional 3,395 shares during the period. Pursue Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,259,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Belpointe Asset Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 30.7% in the second quarter. Belpointe Asset Management LLC now owns 11,382 shares of the exchange traded fund’s stock valued at $1,055,000 after acquiring an additional 2,672 shares in the last quarter. Founders Financial Securities LLC grew its stake in SPDR S&P Biotech ETF by 15.4% in the 2nd quarter. Founders Financial Securities LLC now owns 6,428 shares of the exchange traded fund’s stock valued at $596,000 after purchasing an additional 858 shares during the period. Whalen Wealth Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 33.9% during the 2nd quarter. Whalen Wealth Management Inc. now owns 21,063 shares of the exchange traded fund’s stock worth $1,953,000 after purchasing an additional 5,336 shares during the period. Embree Financial Group purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $297,000. Finally, Financial Counselors Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 8.2% in the 2nd quarter. Financial Counselors Inc. now owns 3,298 shares of the exchange traded fund’s stock worth $306,000 after buying an additional 250 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.1 %

XBI opened at $98.52 on Thursday. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company’s 50-day moving average price is $97.56 and its two-hundred day moving average price is $93.75. The stock has a market cap of $7.51 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.